TB-500 travels in the same circles as BPC-157, the recovery and performance conversation, but it's a distinct compound with its own research story. Here's the level-headed version.

What TB-500 is

TB-500 is a synthetic peptide related to thymosin beta-4, a protein that occurs naturally in the body and is involved in cellular repair and migration. The synthetic version has been studied for its potential role in tissue recovery.

What the research has explored

Studies, again largely in animal models, have looked at TB-500 in the context of wound healing, soft-tissue recovery, and cell migration (the process by which repair cells move to an injury). Researchers have also discussed possible effects on new blood-vessel formation. As with BPC-157, robust human trials are limited.

Worth knowing

TB-500 is not FDA-approved, and it's prohibited in tested sport by anti-doping authorities, an important point for any competitive athlete. Its compounding status sits within the same shifting 2026 picture as other research peptides.

Promising in animal recovery models, unproven in humans, unapproved, and banned in competition, all true at once.

Bottom line

TB-500 is an intriguing recovery-research peptide that's still early, unapproved, and banned in competition. Compare it with its usual counterpart in our BPC-157 vs TB-500 piece, and read the full guide.